Pàgina inicial > Resultats de la cerca: Olsson, Richard F.
  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Resultats globals: 3 registres trobats en 0.02 segons.
Articles, 3 registres trobats
Articles 3 registres trobats  
1.
34 p, 950.5 KB Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies / Pasquini, Marcelo (Medical College of Wisconsin) ; Zhang, Mei-Jie (Medical College of Wisconsin) ; Medeiros, Bruno (Stanford University School of Medicine) ; Armand, Philippe (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Hu, Zhen-Huan (Medical College of Wisconsin) ; Nishihori, Taiga (H. Lee Moffitt Cancer Center and Research Institute) ; Aljurf, Mahmoud D. (King Faisal Specialist Hospital Center and Research) ; Akpek, Görgün (Banner MD Anderson Cancer Center) ; Cahn, Jean-Yves (University Hospital) ; Cairo, Mitchell S. (New York Medical College) ; Cerny, Jan (UMass Memorial Medical Center) ; Copelan, Edward A. (Carolinas HealthCare System) ; Deol, Abhinav (Wayne State University) ; Freytes, César O. (University of Texas Health Science Center San Antonio) ; Gale, Robert Peter (Imperial College London) ; Ganguly, Siddhartha (University of Kansas Medical Center) ; George, Biju (Christian Medical College) ; Gupta, Vikas (University Health Network) ; Hale, Gregory A. (All Children's Hospital) ; Kamble, Rammurti T. (Baylor College of Medicine) ; Klumpp, Thomas R. (Thomas Jefferson University Hospital) ; Lazarus, Hillard M. (University Hospitals Case Medical Center) ; Luger, Selina M. (University of Pennsylvania Medical Center) ; Liesveld, Jane L. (University of Rochester Medical Center) ; Litzow, Mark Robert (Mayo Clinic) ; Marks, David I. (University Hospitals Bristol NHS Trust) ; Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ; Norkin, Maxim (University of Florida College of Medicine) ; Olsson, Richard F. (Uppsala University) ; Oran, Betul (The University of Texas MD Anderson Cancer Center) ; Pawarode, Attaphol (University of Michigan) ; Pulsipher, Michael A. (University of Southern California Keck School of Medicine) ; Ramanathan, Muthalagu (UMass Memorial Medical Center) ; Reshef, Ran (University of Pennsylvania Medical Center) ; Saad, Ayman A. (University of Alabama at Birmingham) ; Saber, Wael (Medical College of Wisconsin) ; Savani, Bipin N. (Vanderbilt University Medical Center) ; Schouten, Harry C. (Academische Ziekenhuis) ; Ringdén, Olle (Centre for Allogeneic Stem Cell Transplantation) ; Tallman, Martin S. (Memorial Sloan Kettering Cancer Center) ; Uy, Geoffrey L. (Washington University School of Medicine) ; Wood, William A. (University of North Carolina) ; Wirk, Baldeep (Seattle Cancer Care Alliance) ; Pérez, Waleska S. (Medical College of Wisconsin) ; Batiwalla, Minoo (National Heart Lung and Blood Institute - National Institutes of Health) ; Weisdorf, Daniel J. (University of Minnesota Medical Center) ; Universitat Autònoma de Barcelona
The presence of monosomal karyotype (MK+) in acute myeloid leukemia (AML) is associated with dismal outcomes. We evaluated the impact of MK+ in AML (MK+AML, n = 240) and in myelodysplastic syndrome (MDS) (MK+MDS, n = 221) on hematopoietic cell transplantation outcomes compared with other cytogenetically defined groups (AML, n = 3360; MDS, n = 1373) as reported to the Center for International Blood and Marrow Transplant Research from 1998 to 2011. [...]
2016 - 10.1016/j.bbmt.2015.08.024
Biology of blood and marrow transplantation, Vol. 22 Núm. 2 (january 2016) , p. 248-257  
Registre complet - Creative Commons
2.
11 p, 547.4 KB Pretransplant Consolidation Is Not Beneficial for Adults with ALL Undergoing Myeloablative Allogeneic Transplantation / Bejanyan, Nelli (University of Minnesota) ; Zhang, Mei-Jie (Medical College of Wisconsin) ; Wang, Hai-Lin (Medical College of Wisconsin) ; Lazaryan, Aleksandr (University of Minnesota) ; de Lima, Marcos (University Hospitals Case Medical Center) ; Marks, David I. (University Hospitals Bristol NHS Trust) ; Sandmaier, Brenda M. (Fred Hutchinson Cancer Research Center) ; Bachanova, Veronika (University of Minnesota) ; Rowe, Jacob (Shaare Zedek Medical Center) ; Tallman, Martin (Memorial Sloan Kettering Cancer Center) ; Kebriaei, Partow (The University of Texas MD Anderson Cancer Center) ; Kharfan-Dabaja, Mohamed (H. Lee Moffitt Cancer Center and Research Institute) ; Peter Gale, Robert (Imperial College London) ; Lazarus, Hillard M. (University Hospitals Cleveland Medical Center) ; Ustun, Celalettin (University of Minnesota) ; Copelan, Edward (Carolinas HealthCare System) ; Ky Hamilton, Betty (Cleveland Clinic Taussig Cancer Institute) ; Schiller, Gary (David Geffen School of Medicine at UCLA) ; Hogan, Willian (Mayo Clinic Rochester) ; Hashmi, Shahrukh (King Faisal Specialist Hospital and Research Centre (Aràbia Saudita)) ; Seftel, Matthew (CancerCare Manitoba) ; Kanakry, Christopher G. (National Institutes of Health (Bethesda, Estats Units d'Amèrica)) ; Olsson, Richard F. (Uppsala University) ; Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ; Saber, Wael (Medical College of Wisconsin) ; Khoury, H.Jean (Emory University Hospital) ; Weisdorf, Daniel J. (University of Minnesota) ; Universitat Autònoma de Barcelona
Allogeneic hematopoietic cell transplantation (alloHCT) is curative for patients with acute lymphoblastic leukemia (ALL) who achieve complete remission (CR1) with chemotherapy. However, the benefit of consolidation chemotherapy remains uncertain in patients undergoing alloHCT. [...]
2018 - 10.1016/j.bbmt.2017.12.784
Biology of blood and marrow transplantation, Vol. 24 Núm. 5 (may 2018) , p. 945-955  
Registre complet - Creative Commons
3.
10 p, 523.7 KB Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide / Im, Annie (University of Pittsburgh/UPMC Hillman Cancer Center) ; Rashidi, Armin (University of Minnesota) ; Wang, Tao (Medical College of Wisconsin) ; Hemmer, Michael (Medical College of Wisconsin) ; MacMillan, Margaret L. (University of Minnesota) ; Pidala, Joseph (H. Lee Moffitt Cancer Center and Research Institute) ; Jagasia, Madan (Vanderbilt University Medical Center) ; Pavletic, Steven (National Cancer Institute of Bethesda) ; Majhail, Navneet S. (Cleveland Clinic Taussig Cancer Institute) ; Weisdorf, Daniel (University of Minnesota) ; Abdel-Azim, Hisham (University of Southern California Keck School of Medicine) ; Agrawal, Vaibhav (Indiana University School of Medicine) ; Al-Homsi, A.Samer (New York University Langone Medical Center) ; Aljurf, Mahmoud (King Faisal Specialist Hospital and Research Centre (Aràbia Saudita)) ; Askar, Medhat (Baylor University Medical Center) ; Auletta, Jeffery J (Nationwide Children's Hospital) ; Bashey, Asad (Blood and Marrow Transplant Program at Northside Hospital) ; Beitinjaneh, Amer (University of Miami) ; Bhatt, Vijaya Raj (University of Nebraska Medical Center) ; Byrne, Michael (Vanderbilt University Medical Center) ; Cahn, Jean-Yves (CHU Grenoble Alpes) ; Cairo, Mitchell S (New York Medical College) ; Castillo, Paul (UF Health Shands Children's Hospital) ; Cerny, Jan (University of Massachusetts Medical Center) ; Chhabra, Saurabh (Medical College of Wisconsin) ; Choe, Hannah (The Ohio State University Wexner Medical Center) ; Ciurea, Stefan (The University of Texas MD Anderson Cancer Center) ; Daly, Andrew (Tom Baker Cancer Center) ; Perez, Miguel Angel Diaz (Hospital Infantil Universitario Nino Jesus) ; Farhadfar, Nosha (University of Florida College of Medicine) ; Gadalla, Shahinaz M. (NIH-NCI Clinical Genetics Branch) ; Gale, Robert (Imperial College London) ; Ganguly, Siddhartha (University of Kansas Health System) ; Gergis, Usama (Thomas Jefferson University) ; Hanna, Rabi (Cleveland Clinic Foundation) ; Hematti, Peiman (University of Wisconsin) ; Herzig, Roger (University of Kentucky Chandler Medical Center) ; Hildebrandt, Gerhard C. (University of Kentucky) ; Lad, Deepesh P. (Postgraduate Institute of Medical Education and Research) ; Lee, Catherine (University of Utah) ; Lehmann, Leslie (Dana-Farber Cancer Institute/Boston Children's Hospital) ; Lekakis, Lazaros (University of Miami) ; Kamble, Rammurti T. (Baylor College of Medicine) ; Kharfan-Dabaja, Momamed A. (Mayo Clinic) ; Khandelwal, Pooja (University of Cincinnati) ; Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ; Murthy, Hemant S. (Mayo Clinic (Jacksonville, Estats Units d'Amèrica)) ; Nishihori, Taiga (H. Lee Moffitt Cancer Center and Research Institute) ; O'Brien, Tracey A. (Sydney Children's Hospital) ; Olsson, Richard F. (Uppsala University) ; Patel, Sagar S. (University of Utah) ; Perales, Miguel-Angel (Memorial Sloan Kettering Cancer Center) ; Prestidge, Tim (Starship Children's Hospital (Auckland, Nova Zelanda)) ; Qayed, Muna (Emory University School of Medicine) ; Romee, Rizwan (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Schoemans, Hélène (University Hospitals Leuven (Bèlgica)) ; Seo, Sachiko (Dokkyo Medical University) ; Sharma, Akshay (St. Jude Children's Research Hospital (Memphis, Estats Units d'Amèrica)) ; Solh, Melhem (Northside Hospital) ; Strair, Roger (Rutgers University) ; Teshima, Takanori (Hokkaido University Hospital) ; Urbano-Ispizua, Alvaro (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Van der Poel, Marjolein (Maastricht University Medical Center) ; Vij, Ravi (Washington University School of Medicine) ; Wagner, John L. (Thomas Jefferson University) ; William, Basem (The Ohio State University) ; Wirk, Baldeep (Penn State Cancer Institute) ; Yared, Jean A. (University of Maryland) ; Spellman, Steve R. (Medical College of Wisconsin) ; Arora, Mukta (University of Minnesota Medical Center) ; Hamilton, Betty K. (Cleveland Clinic Taussig Cancer Institute) ; Universitat Autònoma de Barcelona
Post-transplant cyclophosphamide (PTCy) has significantly increased the successful use of haploidentical donors with a relatively low incidence of graft-versus-host disease (GVHD). Given its increasing use, we sought to determine risk factors for GVHD after haploidentical hematopoietic cell transplantation (haplo-HCT) using PTCy. [...]
2020 - 10.1016/j.bbmt.2020.05.001
Biology of blood and marrow transplantation, Vol. 26 Núm. 8 (august 2020) , p. 1459-1468  
Registre complet - Creative Commons

Vegeu també: autors amb noms similars
4 Olsson, R.F.
3 Olsson, Richard
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem